Sfoglia per Autore
Persistent CD30 Expression by Embryonal Carcinoma in the Treatment Time Course: Prognostic Significance of a Worthwhile Target for Personalized Treatment
2013-01-01 Giannatempo, P; Paolini, B; Miceli, R; Raggi, D; Nicolai, N; Fare, E; Catanzaro, M; Biasoni, D; Torelli, T; Stagni, S; Piva, L; Mariani, L; Salvioni, R; Colecchia, M; Gianni, Am; Necchi, A
Modified cisplatin, etoposide, and ifosfamide (PEI) salvage therapy for male germ cell tumors: long-term efficacy and safety outcomes(dagger)
2013-01-01 Necchi, A; Nicolai, N; Mariani, L; Raggi, D; Fare, E; Giannatempo, P; Catanzaro, M; Biasoni, D; Torelli, T; Stagni, S; Milani, A; Piva, L; Pizzocaro, G; Gianni, Am; Salvioni, R
Impact of Response to Prior Chemotherapy in Patients With Advanced Urothelial Carcinoma Receiving Second-Line Therapy: Implications for Trial Design
2013-01-01 Pond, Gr; Bellmunt, J; Fougeray, R; Choueiri, Tk; Qu, Aq; Niegisch, G; Albers, P; Di Lorenzo, G; Salhi, Y; Galsky, Md; Agarwal, N; Necchi, A; Sonpavde, G
Prostatic metastases from testicular nonseminomatous germ cell cancer: Two case reports and a review of the literature
2013-01-01 Torelli, T.; Lughezzani, G.; Catanzaro, M.; Nicolai, N.; Colecchia, M.; Biasoni, D.; Piva, L.; Maffezzini, M.; Stagni, S.; Necchi, A; Giannatempo, P.; Farè, E.; Salvioni, R.
Erratum: Burden of testicular, paratesticular and extragonadal germ cell tumours in Europe (European Journal of Cancer (2012) 48:2 (159-169))
2013-01-01 Trama, A.; Mallone, S.; Nicolai, N.; Necchi, A.; Schaapveld, M.; Gietema, J.; Znaor, A.; Ardanaz, E.; Berrino, F.
Maintaining success, reducing treatment burden, focusing on survivorship: highlights from the third European consensus conference on diagnosis and treatment of germ-cell cancer
2013-01-01 Beyer, J; Albers, P; Altena, R; Aparicio, J; Bokemeyer, C; Busch, J; Cathomas, R; Cavallin-Stahl, E; Clarke, Nw; Classen, J; Cohn-Cedermark, G; Dahl, Aa; Daugaard, G; De Giorgi, U; De Santis, M; De Wit, M; De Wit, R; Dieckmann, Kp; Fenner, M; Fizazi, K; Flechon, A; Fossa, Sd; Lluch, Jrg; Gietema, Ja; Gillessen, S; Giwercman, A; Hartmann, Jt; Heidenreich, A; Hentrich, M; Honecker, F; Horwich, A; Huddart, Ra; Kliesch, S; Kollmannsberger, C; Krege, S; Laguna, Mp; Looijenga, Lhj; Lorch, A; Lotz, Jp; Mayer, F; Necchi, A; Nicolai, N; Nuver, J; Oechsle, K; Oldenburg, J; Oosterhuis, Jw; Powles, T; Rajpert-De Meyts, E; Rick, O; Rosti, G; Salvioni, R; Schrader, M; Schweyer, S; Sedlmayer, F; Sohaib, A; Souchon, R; Tandstad, T; Winter, C; Wittekind, C
Neoplasie dell'apparato genitale maschile: Carcinoma del Pene
2013-01-01 Salvioni, R; Lughezzani, G; Piva, L; Colecchia, M; Necchi, A
Neoplasie dell'Apparato genitale maschile: Testicolo
2013-01-01 Rosti, G; Salvioni, R; Colecchia, M; Foresta, C; De Giorgi, U; Garolla, A; Necchi, A; Nicolai, N
The Relationship between Characteristics of Inguinal Lymph Nodes and Pelvic Lymph Node Involvement in Penile Squamous Cell Carcinoma: A Single Institution Experience
2014-01-01 Lughezzani, G; Catanzaro, M; Torelli, T; Piva, L; Biasoni, D; Stagni, S; Crestani, A; Guttilla, A; Raggi, D; Giannatempo, P; Necchi, A; Pizzocaro, G; Colecchia, M; Salvioni, R; Nicolai, N
Prognostic risk stratification derived from individual patient level data for men with advanced penile squamous cell carcinoma receiving first-line systemic therapy
2014-01-01 Pond, Gr; Di Lorenzo, G; Necchi, A; Eigl, Bj; Kolinsky, Mp; Chacko, Rt; Dorff, Tb; Harshman, Lc; Milowsky, Mi; Lee, Rj; Galsky, Md; Federico, P; Bolger, G; Deshazo, M; Mehta, A; Goyal, J; Sonpavde, G
Concurrent Chemoradiotherapy for Men With Locally Advanced Penile Squamous Cell Carcinoma
2014-01-01 Pond, Gr; Milowsky, Mi; Kolinsky, Mp; Eigl, Bj; Necchi, A; Harshman, Lc; Di Lorenzo, G; Dorff, Tb; Lee, Rj; Sonpavde, G
Analysis of plasma cytokines and angiogenic factors in patients with pretreated urothelial cancer receiving Pazopanib: the role of circulating interleukin-8 to enhance the prognostic accuracy
2014-01-01 Necchi, A; Pennati, M; Zaffaroni, N; Landoni, E; Giannatempo, P; Raggi, D; Schwartz, Lh; Morosi, C; Crippa, F; Fare, E; Nicolai, N; Lanocita, R; Sava, T; Sacco, C; Messina, C; Ortega, C; De Braud, Fg; Salvioni, R; Daidone, Mg; Gianni, Am; Mariani, L
A nomogram including baseline prognostic factors to estimate the activity of second-line therapy for advanced urothelial carcinoma
2014-01-01 Pond, Gr; Agarwal, N; Bellmunt, J; Choueiri, Tk; Qu, A; Fougeray, R; Vaughn, D; James, Nd; Salhi, Y; Albers, P; Niegisch, G; Galsky, Md; Wong, Yn; Ko, Yj; Stadler, Wm; O'Donnell, Ph; Sridhar, Ss; Vogelzang, Nj; Necchi, A; Di Lorenzo, G; Sternberg, Cn; Mehta, A; Sonpavde, G
Interim Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography for Early Metabolic Assessment of Therapeutic Response to Chemotherapy for Metastatic Transitional Cell Carcinoma
2014-01-01 Giannatempo, P; Alessi, A; Miceli, R; Raggi, D; Fare, E; Nicolai, N; Serafini, G; Padovano, B; Piva, L; Biasoni, D; Torelli, T; Catanzaro, M; Stagni, S; Maffezzini, M; Mariani, L; Gianni, Am; Sonpavde, G; Salvioni, R; Necchi, A; Crippa, F
Combination of Paclitaxel, Cisplatin, and Gemcitabine (TPG) for Multiple Relapses or Platinum-Resistant Germ Cell Tumors: Long-Term Outcomes
2014-01-01 Necchi, A; Nicolai, N; Mariani, L; Lo Vullo, S; Giannatempo, P; Raggi, D; Fare, E; Piva, L; Biasoni, D; Catanzaro, M; Torelli, T; Stagni, S; Milani, A; Gianni, Am; Salvioni, R
Patient Eligibility and Trial Design for the Salvage Therapy of Advanced Urothelial Carcinoma
2014-01-01 Sonpavde, G; Bellmunt, J; Rosenberg, Je; Regazzi, Am; Bajorin, Df; Choueiri, Tk; Qu, Aq; Niegisch, G; Albers, P; Necchi, A; Di Lorenzo, G; Fougeray, R; Wong, Yn; Sridhar, Ss; Ko, Yj; Milowsky, Mi; Galsky, Md; Pond, Gr
Long-Term Efficacy and Safety Outcomes of Modified (Simplified) MVAC (Methotrexate/Vinblastine/Doxorubicin/Cisplatin) as Frontline Therapy for Unresectable or Metastatic Urothelial Cancer
2014-01-01 Necchi, A; Mariani, L; Giannatempo, P; Raggi, D; Fare, E; Nicolai, N; Piva, L; Biasoni, D; Catanzaro, M; Torelli, T; Stagni, S; Maffezzini, M; Pizzocaro, G; De Braud, Fg; Gianni, Am; Salvioni, R
Predictors of CD34(+) Cell Mobilization and Collection in Adult Men With Germ Cell Tumors: Implications for the Salvage Treatment Strategy
2014-01-01 Necchi, A; Miceli, R; Pedrazzoli, P; Giannatempo, P; Secondino, S; Di Nicola, M; Fare, E; Raggi, D; Magni, M; Matteucci, P; Longoni, P; Milanesi, M; Paterno, E; Ravagnani, F; Arienti, F; Nicolai, N; Salvioni, R; Carlo-Stella, C; Gianni, Am
PF-03446962, a fully-human monoclonal antibody against transforming growth-factor beta (TGF beta) receptor ALK1, in pre-treated patients with urothelial cancer: an open label, single-group, phase 2 trial
2014-01-01 Necchi, A; Giannatempo, P; Mariani, L; Fare, E; Raggi, D; Pennati, M; Zaffaroni, N; Crippa, F; Marchiano, A; Nicolai, N; Maffezzini, M; Togliardi, E; Daidone, Mg; Gianni, Am; Salvioni, R; De Braud, F
Comparative effectiveness of gemcitabine plus cisplatin versus methotrexate, vinblastine, doxorubicin, plus cisplatin as neoadjuvant therapy for muscle-invasive bladder cancer
2015-01-01 Galsky, Md; Pal, Sk; Chowdhury, S; Harshman, Lc; Crabb, Sj; Wong, Yn; Yu, Ey; Powles, T; Moshier, El; Ladoire, S; Hussain, Sa; Agarwal, N; Vaishampayan, Un; Recine, F; Berthold, D; Necchi, A; Theodore, C; Milowsky, Mi; Bellmunt, J; Rosenberg, Je
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Persistent CD30 Expression by Embryonal Carcinoma in the Treatment Time Course: Prognostic Significance of a Worthwhile Target for Personalized Treatment | 1-gen-2013 | Giannatempo, P; Paolini, B; Miceli, R; Raggi, D; Nicolai, N; Fare, E; Catanzaro, M; Biasoni, D; Torelli, T; Stagni, S; Piva, L; Mariani, L; Salvioni, R; Colecchia, M; Gianni, Am; Necchi, A | |
| Modified cisplatin, etoposide, and ifosfamide (PEI) salvage therapy for male germ cell tumors: long-term efficacy and safety outcomes(dagger) | 1-gen-2013 | Necchi, A; Nicolai, N; Mariani, L; Raggi, D; Fare, E; Giannatempo, P; Catanzaro, M; Biasoni, D; Torelli, T; Stagni, S; Milani, A; Piva, L; Pizzocaro, G; Gianni, Am; Salvioni, R | |
| Impact of Response to Prior Chemotherapy in Patients With Advanced Urothelial Carcinoma Receiving Second-Line Therapy: Implications for Trial Design | 1-gen-2013 | Pond, Gr; Bellmunt, J; Fougeray, R; Choueiri, Tk; Qu, Aq; Niegisch, G; Albers, P; Di Lorenzo, G; Salhi, Y; Galsky, Md; Agarwal, N; Necchi, A; Sonpavde, G | |
| Prostatic metastases from testicular nonseminomatous germ cell cancer: Two case reports and a review of the literature | 1-gen-2013 | Torelli, T.; Lughezzani, G.; Catanzaro, M.; Nicolai, N.; Colecchia, M.; Biasoni, D.; Piva, L.; Maffezzini, M.; Stagni, S.; Necchi, A; Giannatempo, P.; Farè, E.; Salvioni, R. | |
| Erratum: Burden of testicular, paratesticular and extragonadal germ cell tumours in Europe (European Journal of Cancer (2012) 48:2 (159-169)) | 1-gen-2013 | Trama, A.; Mallone, S.; Nicolai, N.; Necchi, A.; Schaapveld, M.; Gietema, J.; Znaor, A.; Ardanaz, E.; Berrino, F. | |
| Maintaining success, reducing treatment burden, focusing on survivorship: highlights from the third European consensus conference on diagnosis and treatment of germ-cell cancer | 1-gen-2013 | Beyer, J; Albers, P; Altena, R; Aparicio, J; Bokemeyer, C; Busch, J; Cathomas, R; Cavallin-Stahl, E; Clarke, Nw; Classen, J; Cohn-Cedermark, G; Dahl, Aa; Daugaard, G; De Giorgi, U; De Santis, M; De Wit, M; De Wit, R; Dieckmann, Kp; Fenner, M; Fizazi, K; Flechon, A; Fossa, Sd; Lluch, Jrg; Gietema, Ja; Gillessen, S; Giwercman, A; Hartmann, Jt; Heidenreich, A; Hentrich, M; Honecker, F; Horwich, A; Huddart, Ra; Kliesch, S; Kollmannsberger, C; Krege, S; Laguna, Mp; Looijenga, Lhj; Lorch, A; Lotz, Jp; Mayer, F; Necchi, A; Nicolai, N; Nuver, J; Oechsle, K; Oldenburg, J; Oosterhuis, Jw; Powles, T; Rajpert-De Meyts, E; Rick, O; Rosti, G; Salvioni, R; Schrader, M; Schweyer, S; Sedlmayer, F; Sohaib, A; Souchon, R; Tandstad, T; Winter, C; Wittekind, C | |
| Neoplasie dell'apparato genitale maschile: Carcinoma del Pene | 1-gen-2013 | Salvioni, R; Lughezzani, G; Piva, L; Colecchia, M; Necchi, A | |
| Neoplasie dell'Apparato genitale maschile: Testicolo | 1-gen-2013 | Rosti, G; Salvioni, R; Colecchia, M; Foresta, C; De Giorgi, U; Garolla, A; Necchi, A; Nicolai, N | |
| The Relationship between Characteristics of Inguinal Lymph Nodes and Pelvic Lymph Node Involvement in Penile Squamous Cell Carcinoma: A Single Institution Experience | 1-gen-2014 | Lughezzani, G; Catanzaro, M; Torelli, T; Piva, L; Biasoni, D; Stagni, S; Crestani, A; Guttilla, A; Raggi, D; Giannatempo, P; Necchi, A; Pizzocaro, G; Colecchia, M; Salvioni, R; Nicolai, N | |
| Prognostic risk stratification derived from individual patient level data for men with advanced penile squamous cell carcinoma receiving first-line systemic therapy | 1-gen-2014 | Pond, Gr; Di Lorenzo, G; Necchi, A; Eigl, Bj; Kolinsky, Mp; Chacko, Rt; Dorff, Tb; Harshman, Lc; Milowsky, Mi; Lee, Rj; Galsky, Md; Federico, P; Bolger, G; Deshazo, M; Mehta, A; Goyal, J; Sonpavde, G | |
| Concurrent Chemoradiotherapy for Men With Locally Advanced Penile Squamous Cell Carcinoma | 1-gen-2014 | Pond, Gr; Milowsky, Mi; Kolinsky, Mp; Eigl, Bj; Necchi, A; Harshman, Lc; Di Lorenzo, G; Dorff, Tb; Lee, Rj; Sonpavde, G | |
| Analysis of plasma cytokines and angiogenic factors in patients with pretreated urothelial cancer receiving Pazopanib: the role of circulating interleukin-8 to enhance the prognostic accuracy | 1-gen-2014 | Necchi, A; Pennati, M; Zaffaroni, N; Landoni, E; Giannatempo, P; Raggi, D; Schwartz, Lh; Morosi, C; Crippa, F; Fare, E; Nicolai, N; Lanocita, R; Sava, T; Sacco, C; Messina, C; Ortega, C; De Braud, Fg; Salvioni, R; Daidone, Mg; Gianni, Am; Mariani, L | |
| A nomogram including baseline prognostic factors to estimate the activity of second-line therapy for advanced urothelial carcinoma | 1-gen-2014 | Pond, Gr; Agarwal, N; Bellmunt, J; Choueiri, Tk; Qu, A; Fougeray, R; Vaughn, D; James, Nd; Salhi, Y; Albers, P; Niegisch, G; Galsky, Md; Wong, Yn; Ko, Yj; Stadler, Wm; O'Donnell, Ph; Sridhar, Ss; Vogelzang, Nj; Necchi, A; Di Lorenzo, G; Sternberg, Cn; Mehta, A; Sonpavde, G | |
| Interim Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography for Early Metabolic Assessment of Therapeutic Response to Chemotherapy for Metastatic Transitional Cell Carcinoma | 1-gen-2014 | Giannatempo, P; Alessi, A; Miceli, R; Raggi, D; Fare, E; Nicolai, N; Serafini, G; Padovano, B; Piva, L; Biasoni, D; Torelli, T; Catanzaro, M; Stagni, S; Maffezzini, M; Mariani, L; Gianni, Am; Sonpavde, G; Salvioni, R; Necchi, A; Crippa, F | |
| Combination of Paclitaxel, Cisplatin, and Gemcitabine (TPG) for Multiple Relapses or Platinum-Resistant Germ Cell Tumors: Long-Term Outcomes | 1-gen-2014 | Necchi, A; Nicolai, N; Mariani, L; Lo Vullo, S; Giannatempo, P; Raggi, D; Fare, E; Piva, L; Biasoni, D; Catanzaro, M; Torelli, T; Stagni, S; Milani, A; Gianni, Am; Salvioni, R | |
| Patient Eligibility and Trial Design for the Salvage Therapy of Advanced Urothelial Carcinoma | 1-gen-2014 | Sonpavde, G; Bellmunt, J; Rosenberg, Je; Regazzi, Am; Bajorin, Df; Choueiri, Tk; Qu, Aq; Niegisch, G; Albers, P; Necchi, A; Di Lorenzo, G; Fougeray, R; Wong, Yn; Sridhar, Ss; Ko, Yj; Milowsky, Mi; Galsky, Md; Pond, Gr | |
| Long-Term Efficacy and Safety Outcomes of Modified (Simplified) MVAC (Methotrexate/Vinblastine/Doxorubicin/Cisplatin) as Frontline Therapy for Unresectable or Metastatic Urothelial Cancer | 1-gen-2014 | Necchi, A; Mariani, L; Giannatempo, P; Raggi, D; Fare, E; Nicolai, N; Piva, L; Biasoni, D; Catanzaro, M; Torelli, T; Stagni, S; Maffezzini, M; Pizzocaro, G; De Braud, Fg; Gianni, Am; Salvioni, R | |
| Predictors of CD34(+) Cell Mobilization and Collection in Adult Men With Germ Cell Tumors: Implications for the Salvage Treatment Strategy | 1-gen-2014 | Necchi, A; Miceli, R; Pedrazzoli, P; Giannatempo, P; Secondino, S; Di Nicola, M; Fare, E; Raggi, D; Magni, M; Matteucci, P; Longoni, P; Milanesi, M; Paterno, E; Ravagnani, F; Arienti, F; Nicolai, N; Salvioni, R; Carlo-Stella, C; Gianni, Am | |
| PF-03446962, a fully-human monoclonal antibody against transforming growth-factor beta (TGF beta) receptor ALK1, in pre-treated patients with urothelial cancer: an open label, single-group, phase 2 trial | 1-gen-2014 | Necchi, A; Giannatempo, P; Mariani, L; Fare, E; Raggi, D; Pennati, M; Zaffaroni, N; Crippa, F; Marchiano, A; Nicolai, N; Maffezzini, M; Togliardi, E; Daidone, Mg; Gianni, Am; Salvioni, R; De Braud, F | |
| Comparative effectiveness of gemcitabine plus cisplatin versus methotrexate, vinblastine, doxorubicin, plus cisplatin as neoadjuvant therapy for muscle-invasive bladder cancer | 1-gen-2015 | Galsky, Md; Pal, Sk; Chowdhury, S; Harshman, Lc; Crabb, Sj; Wong, Yn; Yu, Ey; Powles, T; Moshier, El; Ladoire, S; Hussain, Sa; Agarwal, N; Vaishampayan, Un; Recine, F; Berthold, D; Necchi, A; Theodore, C; Milowsky, Mi; Bellmunt, J; Rosenberg, Je |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile